首页 > 最新文献

Journal of Virus Eradication最新文献

英文 中文
PP4.2 – 00163 Aging immune system alters HIV/SIV reservoirs PP4.2 - 00163 免疫系统老化改变艾滋病毒/SIV储库
IF 3.5 4区 医学 Q2 IMMUNOLOGY Pub Date : 2024-12-01 DOI: 10.1016/j.jve.2024.100490
S. Byrareddy, S. Debapriya, M. Mahesh, V. Francois, P. Suresh, A. Arpan
{"title":"PP4.2 – 00163 Aging immune system alters HIV/SIV reservoirs","authors":"S. Byrareddy, S. Debapriya, M. Mahesh, V. Francois, P. Suresh, A. Arpan","doi":"10.1016/j.jve.2024.100490","DOIUrl":"10.1016/j.jve.2024.100490","url":null,"abstract":"","PeriodicalId":17552,"journal":{"name":"Journal of Virus Eradication","volume":"10 ","pages":"Page 65"},"PeriodicalIF":3.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143180197","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PP2.8 – 00051 Full-length sequencing of HIV-1 proviruses in large infected cell clones in PWH on ART reveals a predominance of solo-LTRs
IF 3.5 4区 医学 Q2 IMMUNOLOGY Pub Date : 2024-12-01 DOI: 10.1016/j.jve.2024.100478
S. Akter, D. Demirov, D. Brandt, J. Gluck, E.K. Halvas, J. Mellors, X. Wu, S.C. Patro, J.W. Rausch, M.F. Kearney
{"title":"PP2.8 – 00051 Full-length sequencing of HIV-1 proviruses in large infected cell clones in PWH on ART reveals a predominance of solo-LTRs","authors":"S. Akter, D. Demirov, D. Brandt, J. Gluck, E.K. Halvas, J. Mellors, X. Wu, S.C. Patro, J.W. Rausch, M.F. Kearney","doi":"10.1016/j.jve.2024.100478","DOIUrl":"10.1016/j.jve.2024.100478","url":null,"abstract":"","PeriodicalId":17552,"journal":{"name":"Journal of Virus Eradication","volume":"10 ","pages":"Page 57"},"PeriodicalIF":3.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143180589","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Title Page
IF 3.5 4区 医学 Q2 IMMUNOLOGY Pub Date : 2024-12-01 DOI: 10.1016/j.jve.2024.100543
{"title":"Title Page","authors":"","doi":"10.1016/j.jve.2024.100543","DOIUrl":"10.1016/j.jve.2024.100543","url":null,"abstract":"","PeriodicalId":17552,"journal":{"name":"Journal of Virus Eradication","volume":"10 ","pages":"Page i"},"PeriodicalIF":3.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143180778","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PP1.16 – 00059 Identification of solo-LTR HIV provirus in vitro
IF 3.5 4区 医学 Q2 IMMUNOLOGY Pub Date : 2024-12-01 DOI: 10.1016/j.jve.2024.100465
F. Li, G. Li, R. Gorelick, L. Kelly, F. Maldarelli
{"title":"PP1.16 – 00059 Identification of solo-LTR HIV provirus in vitro","authors":"F. Li, G. Li, R. Gorelick, L. Kelly, F. Maldarelli","doi":"10.1016/j.jve.2024.100465","DOIUrl":"10.1016/j.jve.2024.100465","url":null,"abstract":"","PeriodicalId":17552,"journal":{"name":"Journal of Virus Eradication","volume":"10 ","pages":"Page 50"},"PeriodicalIF":3.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143181383","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relatively high interest but limited active engagement in HIV cure research: Awareness, interest, and information-seeking among affected communities in the Netherlands 对艾滋病毒治疗研究的兴趣相对较高,但积极参与有限:荷兰受影响社区的认识、兴趣和信息寻求。
IF 3.5 4区 医学 Q2 IMMUNOLOGY Pub Date : 2024-12-01 DOI: 10.1016/j.jve.2024.100570
Maaike A.J. Noorman , John B.F. de Wit , Tamika A. Marcos , Sarah E. Stutterheim , Thijs Albers , Kai J. Jonas , Chantal den Daas

Background

Community engagement is important for inclusive HIV cure development. This study evaluates current engagement in HIV cure research among affected communities in the Netherlands by analyzing awareness, interest, and information-seeking behavior. It also identifies participant characteristics and HIV-related illness perceptions linked to each engagement stage.

Methods

A cross-sectional survey was conducted from July 2023 to March 2024, involving 499 people with HIV and 578 individuals without HIV, including partners and gay, bisexual, and other men who have sex with men. Multivariate regression analyses examined the relationships between participant characteristics, HIV-related illness perceptions, and three outcomes: awareness, interest, and information-seeking.

Results

The mean awareness was 3.08 (SD = 0.99) interest was higher at 3.67 (SD = 0.85), while the information-seeking frequency was lower at 2.33 (SD = 0.97). Higher awareness was seen in older participants, non-cisgender men, and those with increased perceived control and comprehensibility of HIV. Interest in cure research was higher among people with HIV, those with a migration background, individuals with steady partner(s), and those experiencing greater HIV-related concerns, negative HIV-related emotions, and better HIV comprehension. Information-seeking frequency was greater among people with HIV, those with a bachelor's degree, individuals from a migration background, those with steady partner(s), and those perceiving more severe HIV-related symptoms, and heightened concerns and negative emotions about HIV.

Conclusion

While moderate awareness exists, engagement remains passive with limited information-seeking; however, significant interest in a cure underscores the need for enhanced communication efforts to foster inclusive HIV cure development.
背景:社区参与对包容性艾滋病毒治疗发展非常重要。本研究通过分析意识、兴趣和信息寻求行为,评估了荷兰受影响社区目前参与艾滋病治疗研究的情况。它还确定了参与者的特征和与每个参与阶段相关的艾滋病毒相关疾病的看法。方法:于2023年7月至2024年3月对499名HIV感染者和578名未感染HIV的人进行横断面调查,包括伴侣和同性恋、双性恋和其他男男性行为者。多变量回归分析检验了参与者特征、艾滋病相关疾病认知和三个结果之间的关系:意识、兴趣和信息寻求。结果:平均知晓率为3.08 (SD = 0.99),兴趣度较高,为3.67 (SD = 0.85),信息寻求频率较低,为2.33 (SD = 0.97)。年龄较大的参与者、非顺性男性以及对艾滋病毒的控制和理解程度较高的参与者意识较高。对治疗研究的兴趣在艾滋病毒感染者、有移民背景的人、有稳定伴侣的人、有更大的艾滋病毒相关担忧、消极的艾滋病毒相关情绪和更好的艾滋病毒理解的人中更高。艾滋病毒感染者、拥有学士学位的人、有移民背景的人、有稳定伴侣的人、以及认为艾滋病毒相关症状更严重、对艾滋病毒的担忧和负面情绪加剧的人寻求信息的频率更高。结论:虽然存在适度的意识,但参与仍然是被动的,信息寻求有限;然而,人们对治愈的极大兴趣凸显了加强沟通努力以促进包容性艾滋病毒治愈发展的必要性。
{"title":"Relatively high interest but limited active engagement in HIV cure research: Awareness, interest, and information-seeking among affected communities in the Netherlands","authors":"Maaike A.J. Noorman ,&nbsp;John B.F. de Wit ,&nbsp;Tamika A. Marcos ,&nbsp;Sarah E. Stutterheim ,&nbsp;Thijs Albers ,&nbsp;Kai J. Jonas ,&nbsp;Chantal den Daas","doi":"10.1016/j.jve.2024.100570","DOIUrl":"10.1016/j.jve.2024.100570","url":null,"abstract":"<div><h3>Background</h3><div>Community engagement is important for inclusive HIV cure development. This study evaluates current engagement in HIV cure research among affected communities in the Netherlands by analyzing awareness, interest, and information-seeking behavior. It also identifies participant characteristics and HIV-related illness perceptions linked to each engagement stage.</div></div><div><h3>Methods</h3><div>A cross-sectional survey was conducted from July 2023 to March 2024, involving 499 people with HIV and 578 individuals without HIV, including partners and gay, bisexual, and other men who have sex with men. Multivariate regression analyses examined the relationships between participant characteristics, HIV-related illness perceptions, and three outcomes: awareness, interest, and information-seeking.</div></div><div><h3>Results</h3><div>The mean awareness was 3.08 (SD = 0.99) interest was higher at 3.67 (SD = 0.85), while the information-seeking frequency was lower at 2.33 (SD = 0.97). Higher awareness was seen in older participants, non-cisgender men, and those with increased perceived control and comprehensibility of HIV. Interest in cure research was higher among people with HIV, those with a migration background, individuals with steady partner(s), and those experiencing greater HIV-related concerns, negative HIV-related emotions, and better HIV comprehension. Information-seeking frequency was greater among people with HIV, those with a bachelor's degree, individuals from a migration background, those with steady partner(s), and those perceiving more severe HIV-related symptoms, and heightened concerns and negative emotions about HIV.</div></div><div><h3>Conclusion</h3><div>While moderate awareness exists, engagement remains passive with limited information-seeking; however, significant interest in a cure underscores the need for enhanced communication efforts to foster inclusive HIV cure development.</div></div>","PeriodicalId":17552,"journal":{"name":"Journal of Virus Eradication","volume":"10 4","pages":"Article 100570"},"PeriodicalIF":3.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11697764/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142932015","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-term outcome in people who use drugs successfully treated for hepatitis C infection with glecaprevir/pibrentasvir 使用glecaprevir/pibrentasvir成功治疗丙型肝炎感染者的长期结果。
IF 3.5 4区 医学 Q2 IMMUNOLOGY Pub Date : 2024-12-01 DOI: 10.1016/j.jve.2024.100569
Shana Yi , David Truong , Brian Conway
<div><h3>Background</h3><div>Several clinical trials, including the recently published the GRAND PLAN study from Vancouver Infectious Diseases Center (VIDC), have demonstrated the efficacy of hepatitis C (HCV) therapy among active drug users, including those facing significant addiction-related and social challenges. In the GRAND PLAN, we documented sustained virological response post-treatment Week12 (SVR12) in 108/117 (92.3 %) individuals (108/111 (mITT) or 97.3 % of those reaching the SVR12 timepoint) receiving an 8-week course of glecaprevir/pibrentasvir (G/P), with almost all using fentanyl and over half being unstably housed. Data on the maintenance of this favorable outcome in the long-term in such a population with a significant risk of reinfection is limited. We hypothesized that the offer of ongoing multidisciplinary care (including addiction care) after SVR12 was achieved would reduce the likelihood of loss to follow up, HCV reinfection or death and consolidate the gains achieved by initial engagement in care to diagnose and treat HCV infection.</div></div><div><h3>Methods</h3><div>The inception cohort for this analysis was the 108 individuals achieving a cure of HCV infection within the GRAND PLAN study. All were offered the opportunity to continue to receive care at the VIDC. This is a multidisciplinary model of care to address medical, mental health, social and addiction-related concerns on an ongoing basis. This included, if necessary, opiate agonist and safer supply therapy, usually provided by the pharmacy adjacent to our inner-city campus. Among those choosing to be retained in care, the endpoint of this analysis was loss to follow up, mortality and HCV reinfection and their correlates. Reinfection was ascertained by repeat HCV RNA testing every 6 months, more frequently if clinically indicated.</div></div><div><h3>Results</h3><div>Of the 108 individuals making up the inception cohort for this analysis, all chose to remain in care at the VIDC. We note a median age of 47 (22–75) years, 28 % female, 21.3 % identifying as indigenous, the majority with mild fibrosis (90.8 % F0–F2), slightly more than half with unstable housing. It is of note that we recorded a 20 % decrease in fentanyl users among those who were cured compared to the baseline evaluation of the overall study cohort (73.5 % vs 94.9 %, p < 0.000001). Among the cured individuals, 104 (96.3 %) remained alive, while 4 individuals died of opioid overdoses. Out of the 104 , 99 (95.2 %) remained HCV-free, while 5 (4.8 %) were re-infected. All five have recently initiated repeat HCV therapy at VIDC, 2 of whom are already documented to be cured.</div></div><div><h3>Conclusion</h3><div>Among a population of vulnerable inner-city residents cured of HCV infection within a multidisciplinary program of care at the VIDC, all individuals accepted the offer to remain in long-term follow up, with a statistically significant reduction in fentanyl use over time. In the setting of an o
背景:几项临床试验,包括最近发表的温哥华传染病中心(VIDC)的GRAND PLAN研究,已经证明了丙型肝炎(HCV)治疗对活跃吸毒者的疗效,包括那些面临严重成瘾相关和社会挑战的吸毒者。在GRAND PLAN中,我们记录了108/117(92.3%)人(108/111 (mITT)或97.3%达到SVR12时间点的人)在接受8周疗程的glecaprevir/pibrentasvir (G/P)治疗后第12周(SVR12)持续的病毒学反应,几乎所有人都使用芬太尼,超过一半的人居住不稳定。在这样一个具有显著再感染风险的人群中,长期维持这一有利结果的数据是有限的。我们假设,在达到SVR12后提供持续的多学科护理(包括成瘾护理)将降低随访损失、丙型肝炎病毒再感染或死亡的可能性,并巩固最初参与诊断和治疗丙型肝炎病毒感染所取得的成果。方法:本分析的初始队列是GRAND PLAN研究中治愈HCV感染的108例个体。所有人都有机会继续在VIDC接受治疗。这是一种多学科的护理模式,旨在持续解决医疗、心理健康、社会和成瘾相关问题。这包括,如有必要,阿片类激动剂和更安全的供应治疗,通常由我们市中心校园附近的药房提供。在那些选择继续护理的患者中,本分析的终点是失去随访、死亡率和丙型肝炎病毒再感染及其相关因素。通过每6个月重复HCV RNA检测来确定再感染,如果有临床指征则更频繁。结果:在本分析的初始队列中,108名个体均选择继续在VIDC接受治疗。我们注意到患者的中位年龄为47岁(22-75岁),28%为女性,21.3%为土著,大多数为轻度纤维化(90.8%为F0-F2),略多于一半的患者住房不稳定。值得注意的是,与总体研究队列的基线评估相比,我们记录到治愈的芬太尼使用者减少了20% (73.5% vs 94.9%, p结论:在VIDC的多学科护理计划中治愈了HCV感染的弱势市中心居民人群中,所有人都接受了继续进行长期随访的建议,随着时间的推移,芬太尼的使用有统计学意义的显著减少。在持续发生阿片类药物危机的情况下,在研究人群居住的社区每天记录3例死亡,我们记录了4例死亡。再次感染的发生率非常低,维持护理可以及时重新治疗,2/5的病例已经治愈,其他3人继续在VIDC接受HCV治疗。
{"title":"Long-term outcome in people who use drugs successfully treated for hepatitis C infection with glecaprevir/pibrentasvir","authors":"Shana Yi ,&nbsp;David Truong ,&nbsp;Brian Conway","doi":"10.1016/j.jve.2024.100569","DOIUrl":"10.1016/j.jve.2024.100569","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Background&lt;/h3&gt;&lt;div&gt;Several clinical trials, including the recently published the GRAND PLAN study from Vancouver Infectious Diseases Center (VIDC), have demonstrated the efficacy of hepatitis C (HCV) therapy among active drug users, including those facing significant addiction-related and social challenges. In the GRAND PLAN, we documented sustained virological response post-treatment Week12 (SVR12) in 108/117 (92.3 %) individuals (108/111 (mITT) or 97.3 % of those reaching the SVR12 timepoint) receiving an 8-week course of glecaprevir/pibrentasvir (G/P), with almost all using fentanyl and over half being unstably housed. Data on the maintenance of this favorable outcome in the long-term in such a population with a significant risk of reinfection is limited. We hypothesized that the offer of ongoing multidisciplinary care (including addiction care) after SVR12 was achieved would reduce the likelihood of loss to follow up, HCV reinfection or death and consolidate the gains achieved by initial engagement in care to diagnose and treat HCV infection.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Methods&lt;/h3&gt;&lt;div&gt;The inception cohort for this analysis was the 108 individuals achieving a cure of HCV infection within the GRAND PLAN study. All were offered the opportunity to continue to receive care at the VIDC. This is a multidisciplinary model of care to address medical, mental health, social and addiction-related concerns on an ongoing basis. This included, if necessary, opiate agonist and safer supply therapy, usually provided by the pharmacy adjacent to our inner-city campus. Among those choosing to be retained in care, the endpoint of this analysis was loss to follow up, mortality and HCV reinfection and their correlates. Reinfection was ascertained by repeat HCV RNA testing every 6 months, more frequently if clinically indicated.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;div&gt;Of the 108 individuals making up the inception cohort for this analysis, all chose to remain in care at the VIDC. We note a median age of 47 (22–75) years, 28 % female, 21.3 % identifying as indigenous, the majority with mild fibrosis (90.8 % F0–F2), slightly more than half with unstable housing. It is of note that we recorded a 20 % decrease in fentanyl users among those who were cured compared to the baseline evaluation of the overall study cohort (73.5 % vs 94.9 %, p &lt; 0.000001). Among the cured individuals, 104 (96.3 %) remained alive, while 4 individuals died of opioid overdoses. Out of the 104 , 99 (95.2 %) remained HCV-free, while 5 (4.8 %) were re-infected. All five have recently initiated repeat HCV therapy at VIDC, 2 of whom are already documented to be cured.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Conclusion&lt;/h3&gt;&lt;div&gt;Among a population of vulnerable inner-city residents cured of HCV infection within a multidisciplinary program of care at the VIDC, all individuals accepted the offer to remain in long-term follow up, with a statistically significant reduction in fentanyl use over time. In the setting of an o","PeriodicalId":17552,"journal":{"name":"Journal of Virus Eradication","volume":"10 4","pages":"Article 100569"},"PeriodicalIF":3.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11728950/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142979063","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ST1.1 – 00095 Single cell transcriptomic characterization of the gastrointestinal HIV reservoir
IF 3.5 4区 医学 Q2 IMMUNOLOGY Pub Date : 2024-12-01 DOI: 10.1016/j.jve.2024.100442
E. Browne, J. Peterson, E. Bennett, C. White, S. Chandel, K. James, B. Allard, M. Clohosey, T. Whitaker, C. Baker, S. Pedersen, A. Peery, C. Gay, D. Margolis, N. Archin
{"title":"ST1.1 – 00095 Single cell transcriptomic characterization of the gastrointestinal HIV reservoir","authors":"E. Browne,&nbsp;J. Peterson,&nbsp;E. Bennett,&nbsp;C. White,&nbsp;S. Chandel,&nbsp;K. James,&nbsp;B. Allard,&nbsp;M. Clohosey,&nbsp;T. Whitaker,&nbsp;C. Baker,&nbsp;S. Pedersen,&nbsp;A. Peery,&nbsp;C. Gay,&nbsp;D. Margolis,&nbsp;N. Archin","doi":"10.1016/j.jve.2024.100442","DOIUrl":"10.1016/j.jve.2024.100442","url":null,"abstract":"","PeriodicalId":17552,"journal":{"name":"Journal of Virus Eradication","volume":"10 ","pages":"Page 33"},"PeriodicalIF":3.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143128519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
8.2 – 00072 Early intervention with an indoline CD4-mimetic compound that sensitizes HIV-1-infected cells to ADCC favors post-treatment HIV control in humanized mice
IF 3.5 4区 医学 Q2 IMMUNOLOGY Pub Date : 2024-12-01 DOI: 10.1016/j.jve.2024.100437
L. Zhu, H. Kim, J. Richard, L. Marchitto, C.J. Fritschi, D. Yang, S.L.T. Boodapati, Y. Sun, H.-C. Chen, G. Beaudoin-Bussières, M. Benlarbi, É. Bélanger, K. Dionne, D. Chatterjee, C. Bourassa, H. Medjahed, F. Gaudette, M.A. Brehm, D.L. Greiner, L.D. Shultz, P. Kumar
{"title":"8.2 – 00072 Early intervention with an indoline CD4-mimetic compound that sensitizes HIV-1-infected cells to ADCC favors post-treatment HIV control in humanized mice","authors":"L. Zhu,&nbsp;H. Kim,&nbsp;J. Richard,&nbsp;L. Marchitto,&nbsp;C.J. Fritschi,&nbsp;D. Yang,&nbsp;S.L.T. Boodapati,&nbsp;Y. Sun,&nbsp;H.-C. Chen,&nbsp;G. Beaudoin-Bussières,&nbsp;M. Benlarbi,&nbsp;É. Bélanger,&nbsp;K. Dionne,&nbsp;D. Chatterjee,&nbsp;C. Bourassa,&nbsp;H. Medjahed,&nbsp;F. Gaudette,&nbsp;M.A. Brehm,&nbsp;D.L. Greiner,&nbsp;L.D. Shultz,&nbsp;P. Kumar","doi":"10.1016/j.jve.2024.100437","DOIUrl":"10.1016/j.jve.2024.100437","url":null,"abstract":"","PeriodicalId":17552,"journal":{"name":"Journal of Virus Eradication","volume":"10 ","pages":"Page 29"},"PeriodicalIF":3.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143130230","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PP1.12 – 00061 Nanopore sequencing enables capturing of long HIV-1 reads for multi-omic analysis of HIV-1-infected cells
IF 3.5 4区 医学 Q2 IMMUNOLOGY Pub Date : 2024-12-01 DOI: 10.1016/j.jve.2024.100461
Y. Qi, H. Courtney, A. Courtney, T. Lu, L. Vella
{"title":"PP1.12 – 00061 Nanopore sequencing enables capturing of long HIV-1 reads for multi-omic analysis of HIV-1-infected cells","authors":"Y. Qi,&nbsp;H. Courtney,&nbsp;A. Courtney,&nbsp;T. Lu,&nbsp;L. Vella","doi":"10.1016/j.jve.2024.100461","DOIUrl":"10.1016/j.jve.2024.100461","url":null,"abstract":"","PeriodicalId":17552,"journal":{"name":"Journal of Virus Eradication","volume":"10 ","pages":"Page 48"},"PeriodicalIF":3.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143131884","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
5.3 – 00106 Macrophage-tropic TF SHIV D infected NHP model of reservoir persistence, decay and pathogenesis on suppressive anti-retroviral therapy
IF 3.5 4区 医学 Q2 IMMUNOLOGY Pub Date : 2024-12-01 DOI: 10.1016/j.jve.2024.100420
S. Mallick, R. Krause, A.G. Mcfarland, H. Schrader, G.D. Whitehill, F.E. Marino, R. Podgorski, E. Lewis, G.M. Shaw, T. Burdo, Katharine J. Bar
{"title":"5.3 – 00106 Macrophage-tropic TF SHIV D infected NHP model of reservoir persistence, decay and pathogenesis on suppressive anti-retroviral therapy","authors":"S. Mallick,&nbsp;R. Krause,&nbsp;A.G. Mcfarland,&nbsp;H. Schrader,&nbsp;G.D. Whitehill,&nbsp;F.E. Marino,&nbsp;R. Podgorski,&nbsp;E. Lewis,&nbsp;G.M. Shaw,&nbsp;T. Burdo,&nbsp;Katharine J. Bar","doi":"10.1016/j.jve.2024.100420","DOIUrl":"10.1016/j.jve.2024.100420","url":null,"abstract":"","PeriodicalId":17552,"journal":{"name":"Journal of Virus Eradication","volume":"10 ","pages":"Pages 17-18"},"PeriodicalIF":3.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143180806","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Virus Eradication
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1